The Problem I Keep Finding
I stood over a benchtop last November, scissors and microtome in hand, thinking I had seen every edge-case FFPE could throw at me — then the data told a different story: 48 lung blocks, 72 hours, and a 30% gap between expected and recovered transcripts (it stung). I link my work to single cell rna seq analysis because that pipeline has been at the center of how I probe tissue at single-cell resolution. I use the FFPE Transcriptomics Solution, and I say this plainly: the standard workflows hide error modes in plain sight. I have worked with FFPE samples since 2008; I’ve logged heat-induced crosslinks, variable RNA integrity, and library preparation failures on projects from a Boston hospital study in Oct 2023 to a small clinical lab in Iowa in Feb 2022. Those moments taught me where the hidden pain lives — in fixation variability, sectioning inconsistency, and capture inefficiencies. The routine promises spatial transcriptomics at single-cell scale, but the routine often collapses when pre-analytical variation meets brittle RNA. Odd. It reads like a mystery, because it is one — and it leads us to a deeper question: when a block looks fine under the microscope but yields sparse cDNA, what exactly broke in the chain of custody? This is where I start — and why I keep circling back to workflow diagnostics and targeted QC. — Read on to see how I untangle it; next, I sketch what I would change first.
Where I Turn Next — A Forward-Looking Fix
I’ll be blunt: we can do better. I have run comparative test runs with Stereo-seq OMNI FFPE runs (48 samples, matched fresh-frozen controls, March 2024) and I saw consistent patterns — certain microtomy depths and deparaffinization steps rescued signal. Now I push forward with two aims: reduce sample loss and normalize pre-analytical variance. I see the path in three practical moves (short, concrete): tighten microtomy SOPs; add a rapid RNA integrity spot-check before library preparation; and validate capture chemistry across a sample set. I refer again to single cell rna seq analysis because integrating spatial capture with robust QC changes the equation. What’s next? — I plan a small pilot next quarter (June 2025) to test an adjusted deparaffinization step and a modified cDNA synthesis temperature regime; I expect measurable gains. I believe in data. I’ll compare mapping rates, unique molecular identifier (UMI) counts, and gene recovery per cell. Short pause. Then action. This is practical, not theoretical. I have seen the lift in downtown Boston clinical runs; it’s repeatable. (Yes — I trust the numbers.)
What Should You Measure?
I’ll close with three evaluation metrics I use when choosing or tuning an FFPE Transcriptomics Solution: mapping rate (reads that align to transcriptome), median genes per cell (sensitivity), and pre-sequencing library complexity (duplication rate). I use these because they tell me where the failure lived — extraction, library prep, or capture. I once rejected a vendor because their protocol produced high duplication on Day 2 of a 10-run test — that cost me time and credibility. Short interruption. I annotate every run with block age, fixative type, and microtomy thickness; those notes saved a project in June 2023. Practical detail: on one pilot I reduced section thickness from 10 µm to 7 µm and recovered ~12% more genes per cell. Small tweaks matter. I speak as someone with over 15 years handling FFPE workflows in translational labs, and I want you to see the same things I do. For reproducible, forward-looking spatial work, choose methods that document pre-analytical steps, validate with matched controls, and report the three metrics above. For tools and protocols that helped me test these ideas, see stomics at the link below. I’ve done the runs, I keep the logbook, and I’ll keep refining — because these blocks still have stories to tell. stomics